Data supplements
EBM Resources
Files in this Data Supplement:
- Tips for teachers of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat -
A companion version of this article directed at teachers of evidence-based medicine [207 KB PDF]
An interactive version of this article as well as other tools and resources can be found at www.ebmtips.net/ci001.asp
- Tips for teachers of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat -
A companion version of this article directed at teachers of evidence-based medicine [207 KB PDF]
In this issue
Article tools
Respond to this article
Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat
Jump to section
Related Articles
Cited By...
- Increased risk of many early-life diseases after surgical removal of adenoids and tonsils in childhood
- Presenting risk information in sexual and reproductive health care
- Event-rate and delta inflation when evaluating mortality as a primary outcome from randomized controlled trials of nutritional interventions during critical illness: a systematic review
- Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation
- Partial sick leave associated with disability pension: propensity score approach in a register-based cohort study
- Use of relative and absolute effect measures in reporting health inequalities: structured review
- Absolute risk, relative risk, and number needed to treat
- Pursuing Board of Pharmacy Specialties certification
- Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis
- Not-so-surprising findings.
- Teaching evidence-based practice on foot
- Teaching evidence-based practice on foot
- Challenges of teaching EBM
- When should I stop anticoagulation for atrial fibrillation?
- Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results
- NNT for studies with long-term follow-up
- NNT for studies with long-term follow-up
- Le Vioxx : lecons pour Sante Canada et la FDA
- Vioxx: lessons for Health Canada and the FDA
- Editor's note
- Views on recertification
- Tips for learners of evidence-based medicine: 2. Measures of precision (confidence intervals)
- Tips for learning and teaching evidence-based medicine: introduction to the series